EVP, CFO and Sec. of Chemocentryx Inc (30-Year Financial, Insider Trades) Susan M Kanaya (insider trades) sold 311,625 shares of CCXI on 11/26/2019 at an average price of $31.51 a share. The total sale was $9.8 million.
ChemoCentryx Inc is a biopharmaceutical company. It is engaged in discovering, developing and commercializing orally-administered therapeutics to treat autoimmune diseases, inflammatory disorders and cancer. ChemoCentryx Inc has a market cap of $1.73 billion; its shares were traded at around $29.76 with and P/S ratio of 45.78. GuruFocus has detected 1 severe warning sign with ChemoCentryx Inc. .
CEO Recent Trades:
- President and CEO Thomas J. Schall sold 279,166 shares of CCXI stock on 11/26/2019 at the average price of $31.55. The price of the stock has decreased by 5.67% since.
CFO Recent Trades:
- EVP, CFO and Sec. Susan M Kanaya sold 311,625 shares of CCXI stock on 11/26/2019 at the average price of $31.51. The price of the stock has decreased by 5.55% since.
Directors and Officers Recent Trades:
- Chief Bus. Officer & Treasurer Markus J. Cappel sold 330,524 shares of CCXI stock on 11/26/2019 at the average price of $32.03. The price of the stock has decreased by 7.09% since.
For the complete insider trading history of CCXI, click here
.- CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
- Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
- Double Buys: Companies that both Gurus and Insiders are buying
- Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.
